Home > Press > A Penn Business-Opportunity Panel Discussion: "Nanotechnology: Small Science, Big Business"
A Penn Business-Opportunity Panel Discussion: "Nanotechnology: Small Science, Big Business"
Philadelphia, PA | Posted on October 15th, 2007
WHAT: Penn's Executive Master's in Technology Management
Program has gathered experts in nanotechnology commercialization
and technology transfer to discuss nanotechnology ventures and funding. Topics include the role of IP, market pull, funding, university research and collaboration and elements for success of a start-up. Penn's EMTM program is a two-year executive program based in the School of Engineering and Applied Science and co- sponsored by Penn's Wharton School.
WHERE: Wu and Chen Auditorium, Levine Hall, 34th and Walnut streets on the campus of the University of Pennsylvania
WHEN: Friday, Oct. 26, 2007, 6 p.m.
PANEL:
David Hsu of Wharton, panel moderator, an associate editor of
Management Science and an expert in entrepreneurial innovation
Daryl Boudreaux, a partner in NanoHoldings LLC
Vincent Caprio, founder and executive director of the national NanoBusiness Alliance
Erli Chen, director of Nanotechnology Licensing for Penn‚s Center for Technology Transfer and former head of the Nanofabrication Group at Harvard University's Center for Nanoscale Systems
Anthony P. Green, vice president of the Technology Commercialization Group: Life Sciences for Ben Franklin Technology Partners of Southeastern Pennsylvania and Ben Franklin Director of The Nanotechnology Institute
####
For more information, please click here
Contacts:
Jordan Reese
215-573-6604
Copyright © University of Pennsylvania
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
Academic/Education
Rice University launches Rice Synthetic Biology Institute to improve lives January 12th, 2024
Multi-institution, $4.6 million NSF grant to fund nanotechnology training September 9th, 2022
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
Events/Classes
A New Blue: Mysterious origin of the ribbontail ray’s electric blue spots revealed July 5th, 2024
Researchers demonstrate co-propagation of quantum and classical signals: Study shows that quantum encryption can be implemented in existing fiber networks January 20th, 2023
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||